-
Extensive destruction in Beirut's southern suburbs following Israeli strikes
-
Most Asian equities drop as Mideast crisis rages, though oil dips
-
'Super special' Allen can light up big occasion for New Zealand
-
'Genie' Bumrah: India's yorker king who carries a billion hopes
-
'There will be nerves': India face New Zealand for T20 World Cup glory
-
Lufthansa warns of heightened 'uncertainty' from Mideast war
-
Mideast war enters 'next phase' as strikes hit Iran, Lebanon
-
Equities mixed as Mideast crisis rages, though oil dips
-
Sri Lanka denounces war deaths, houses Iran sailors
-
Inoue primed for 'historic' Nakatani clash in Tokyo
-
Italy challenges EU over key climate tool
-
Home hero Piastri edges Antonelli in second Australian GP practice
-
Australia forces porn sites to block under-18s from Monday
-
Ukraine accuses Hungary of taking 'hostage' bank staff carrying $40 mn
-
Aston Martin chief Newey says no quick fix to vibration problems
-
Japan approves stem-cell treatment for Parkinson's in world first
-
Heavy attacks hit Tehran as Israel says war in 'new phase'
-
North Korea thrash Bangladesh in Women's Asian Cup warning
-
Hong Kong mogul Jimmy Lai will not appeal national security conviction: lawyer
-
Eight dead, four missing in Brazil seniors home collapse
-
Paralympics brace for tense opening as Russia comes in from the cold
-
Leclerc edges Hamilton to go fastest in first Australian GP practice
-
Equities mostly drop as Mideast crisis rages, though oil dips
-
Nepal counts votes after key post-uprising election
-
Italy half-backs can make difference against England: ex-coach Mallett
-
Scotland coach Townsend hails 'instinctive' France ahead of key Six Nations game
-
French starlet Seixas to take on Pogacar at Strade Bianche
-
Brazil's Petrobras sees profit soar on record output
-
Arsenal, Chelsea aim to avoid FA Cup upsets
-
Middle East war enters seventh day as Israel strikes Beirut
-
Qualifier Parry ends Venus's desert dream
-
Iran missile barrage sparks explosions over Tel Aviv
-
US says Venezuela to protect mining firms as diplomatic ties restored
-
Trump honors Messi and MLS Cup champion Miami teammates
-
Dismal Spurs can still avoid relegation vows Tudor
-
Berger sets early pace at Arnold Palmer with 'unbelievable' 63
-
Morocco part company with coach Regragui as World Cup looms
-
Lens beat Lyon on penalties to reach French Cup semis
-
El Salvador's Bukele holding dozens of political prisoners: rights group
-
With Iran war, US goes it alone like never before
-
Spurs slip deeper into relegation trouble after loss to Palace
-
European, US stocks back in sell-off mode as oil prices surge
-
Pete Hegseth: Trump's Iran war attack dog
-
Celtics' Tatum could make injury return on Friday
-
'Enemy at home': Iranian authorities tighten grip as war rages
-
Bethell set for 'hell of a career', says England captain Brook
-
France coach Galthie slams Scotland for 'smallest changing room in the world'
-
Medvedev arrives in Indian Wells after being stranded in Dubai
-
Trump fires homeland security chief Kristi Noem
-
Mideast war risks pulling more in as conflict boils over
Chile launches vaccine that neuters dogs for a year
Chile has launched a vaccine described as the first of its kind that sterilizes dogs for a year and is expected to be sold in several dozen countries.
The injection prevents sexual behavior and reproduction, offering an alternative to irreversible surgical castration, its creators say.
"This is the first vaccine of this type in the world for dogs," said Leonardo Saenz, from the University of Chile's veterinary sciences faculty.
The researcher and his team have been working since 2009 to develop the vaccine, which began to be distributed this month in the South American nation.
It stimulates antibodies and stops the production of sex hormones for a year in both male and female dogs.
"Everything is blocked: sexual activity and fertility," Saenz said.
The Egalitte vaccine has been patented in 40 countries, including the United States, Argentina, and Brazil, as well as in the European Union.
In Chile, it costs $50 a shot.
Ivan Gutierrez, a 27-year-old student, took his dog Franchesco to a veterinary clinic in Santiago to be given the injection.
"I didn't really want him to have the operation," he said.
He is not alone in having concerns about surgical castration.
"Most owners are afraid of surgery," said Mariela del Saz, the clinic's veterinarian, noting the risk of cardiorespiratory arrest.
Another method of temporary castration for dogs involves the insertion of a hormonal implant under the skin, but it "can cause side effects," Saenz said.
T.Germann--VB